First Time Loading...

Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390

Watchlist Manager
Guizhou Xinbang Pharmaceutical Co Ltd Logo
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Watchlist
Price: 3.67 CNY 0.27% Market Closed
Updated: Jun 3, 2024

Guizhou Xinbang Pharmaceutical Co Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Guizhou Xinbang Pharmaceutical Co Ltd
Current Portion of Long-Term Debt Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Current Portion of Long-Term Debt
¥4.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Current Portion of Long-Term Debt
¥599.8m
CAGR 3-Years
39%
CAGR 5-Years
53%
CAGR 10-Years
2%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Current Portion of Long-Term Debt
¥4.2B
CAGR 3-Years
625%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Current Portion of Long-Term Debt
¥33.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
7%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Current Portion of Long-Term Debt
¥74.7m
CAGR 3-Years
-57%
CAGR 5-Years
-47%
CAGR 10-Years
N/A

See Also

What is Guizhou Xinbang Pharmaceutical Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
4.4m CNY

Based on the financial report for Mar 31, 2024, Guizhou Xinbang Pharmaceutical Co Ltd's Current Portion of Long-Term Debt amounts to 4.4m CNY.

What is Guizhou Xinbang Pharmaceutical Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 1Y
75%

Over the last year, the Current Portion of Long-Term Debt growth was 75%.